Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-91 (Carton); 13668-473-70 (Blister)
Published June 11, 2025 · Recall initiated: May 27, 2025
Summary
FDA records drug Class II recall D-0456-2025, published June 11, 2025 and initiated May 27, 2025. Recalling firm: Torrent Pharma Inc.; Status: Completed; Reported quantity: 972 Cartons; Lot: Lot# BDX6K001; Exp. Date: 06/30/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.
What to do
Voluntary: Firm initiated · E-Mail
Get an email if FLUOXETINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FLUOXETINE
- Manufacturer
- Torrent Pharma Inc.
- Distributor
- U.S. Nationwide.
- UPC
- 0313668443301
- Lot
- Lot# BDX6K001; Exp. Date: 06/30/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD.,June 11, 2025
- FDALacosamide Oral Solution, USP, 10 mg/mL, 200 mL, Rx Only, Manufactured by: Apotex Inc., Toronto, Ontario,June 11, 2025
- FDAIndomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only,June 11, 2025
- FDAFluoxetine Capsules USP, 20 mg, packaged in a) 500-count bottles (NDC 50111-648-02), and (b) 1000- countMay 6, 2015
- FDAFluoxetine Capsules USP, 20 mg, packaged in a) 100-count bottles (NDC 50111-648-01), b) 500-count bottles (NDCMay 7, 2014
- FDAFluoxetine Capsules USP, 10 mg, 100-count bottles, Rx only, Manufactured in Poland By: Pliva KrakowMay 7, 2014
Questions about this recall
Was Fluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD., Indrad-382 721 INDIA; Manufactured for: TORRENT PHARMA INC., Basking Ridge, NJ 07920. NDC: 13668-473-91 (Carton); 13668-473-70 (Blister) recalled?
Yes. FDA published recall D-0456-2025 on June 11, 2025. Reported hazard: CGMP Deviations: Presence of N-Nitroso Fluoxetine exceeding interim acceptable intake limit.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FLUOXETINE. UPC: 0313668443301.